31-01-2020 16:00 via medpagetoday.com

FDA OK's Trijardy XR; Dual Hormone Artificial Pancreas

]]>(MedPage Today) -- The FDA approved Boehringer Ingelheim and Eli Lilly's triple action extended release diabetes pill Trijardy XR, combining empagliflozin (Jardiance), linagliptin (Tradjenta), and metformin hydrochloride.A dual hormone artificial...
Read more »